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SIGNIFICANCE STATEMENT 
Sprouty1 is a critical regulator of genitourinary development that ensures that only one 
kidney per side of the embryo is formed. The molecular mechanisms by which Sprouty1 
exerts this function are largely unknown. Here we demonstrate that removing a single 
tyrosine from Sprouty1 in vivo is enough to inactivate its function during genitourinary 
development. Knockin mice lacking this tyrosine present supernumerary kidneys, 
megaureter and vesicoureteral reflux, thus phenocopying Sprouty1 knockout mice. These 
findings shed light on the elusive mechanisms of action of Sprouty proteins, and provide a 
valuable tool to investigate the developmental origin of human congenital anomalies of 
kidney and lower urinary tract (CAKUT).  
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SUMMARY 
Background: Congenital anomalies of the kidney and urinary tract (CAKUT) is a group of 
diseases that include a broad spectrum of developmental defects of the genitourinary 
system. Mouse models indicate that perturbations of the GDNF-Ret signaling pathway are a 
major genetic cause of CAKUT. Sprouty1 is an intracellular Ret inhibitor whose mutation 
results in supernumerary kidneys, megaureters, and hydronephrosis in mice. Both the 
molecular mechanisms and the structural domains critical for Sprouty function are a matter 
of controversy, partly because studies pursuing this objective rely on ectopic 
overexpression in cell lines. A conserved N-terminal tyrosine has been frequently, but not 
always, identified as critical for their function in vitro. 
Methods: We have generated Sprouty1 knockin mice bearing a tyrosine-to-alanine 
substitution in position 53, corresponding to the conserved N-terminal tyrosine of Sprouty1. 
We have characterized development of the genitourinary systems of these mice via 
different methods, including the use of reporter mice expressing EGFP form the Ret locus, 
and whole mount cytokeratin staining.  
Results: Mice lacking this tyrosine grow ectopic ureteric buds that ultimately will form 
supernumerary kidneys, a phenotype indistinguishable to that of Sprouty1 knockout mice. 
Sprouty1 knockin mice also present megaureters and vesicoureteral reflux, caused by 
failure of ureters to separate from Wolffian ducts and migrate to their definitive position. 
Conclusions: Tyrosine 53 is absolutely necessary to convey Sprouty1 function during 
genitourinary development. 
 
 
 
 
 
Keywords: Sprouty, Ret, Genitourinary Development, Wolffian Duct, Ureteric bud 
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INTRODUCTION 
Congenital anomalies of the kidney and urinary tract (CAKUT) is a group of diseases 
affecting ~1/500 of human births, and the main cause of pediatric chronic kidney disease. It 
includes a broad spectrum of developmental defects including renal agenesis, 
hydronephrosis, vesicoureteral junction obstruction, megaureter, and vesicoureteral reflux1.  
Development of definitive (metanephric) kidneys begins around embryonic day 10.5 
(E10.5) with an outgrowth of the Wolffian duct (WD) termed the ureteric bud (UB), that 
will repeatedly branch to ultimately generate the ureter and the collecting duct system of 
the kidney. Both the emergence and ulterior branching of the UB are triggered by signals 
emanating from the receptor tyrosine kinase Ret, which is expressed in the UB epithelium. 
Ret becomes activated upon binding to its ligand Glial cell line-derived neurotrophic factor 
(GDNF), secreted by the adjacent metanephric mesenchyme. Knockout mice lacking 
GDNF, Ret or its co-receptor GFRα1 fail to generate the ureteric bud and consequently die 
at birth owing to renal agenesis2. Later during development, ureters detach from the WD 
and migrate to their final position at the bladder in a process known as ureter maturation. 
This remodeling process involves apoptosis of the portion of the WD between the bladder 
wall and the ureter, known as the common nephric duct (cnd), as well as migration of the 
distal tip of ureters to their definitive location at the bladder wall 3, 4. Defective ureter 
maturation leads to vesicoureteral junction obstruction, hydronephrosis, hydroureter or 
vesicoureteral reflux. Interestingly, the GDNF-GFRα1-Ret signaling axis is also a major 
genetic pathway governing ureter maturation 5. 
Sprouty family of genes is composed of four members in mammals (Spry1-4), orthologous 
to a single Drosophila melanogaster gene (dSpry). dSpry gene product is a 63 kDa protein 
containing a cysteine-rich domain (CRD) in its C-terminus which is conserved across 
species 6. Outside the CRD, there is little sequence homology between Sprouty family 
members, except for a short stretch of aminoacids surrounding a conserved tyrosine (Tyr53 
in Spry1), and a serine-rich domain (SRD) present in all four mammalian Sprouty proteins 
but poorly conserved in dSpry 7.  
Genetic experiments in mice clearly establish that Sprouty family members are negative 
regulators of signaling by Ret during development. Thus, deletion of Spry2 leads to 
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hyperplasia of the enteric nervous system as a result of excessive Ret signaling 8, whereas 
Spry1 antagonizes Ret signaling during kidney morphogenesis 9, 10. Mice deficient in 
Sprouty1 grow more than one ureteric bud per side of the embryo, thus giving rise to 
supernumerary kidneys that fuse together into a single anatomic unit. At birth, these 
animals also present massively dilated ureters (megaureters), multiple cystic cavities inside 
the kidney parenchyma, and dilation of kidney tubules (hydronephrosis). Epistasis 
experiments reveal that the underlying cause of such phenotype is excessive activation of 
the GDNF-GFRα1-Ret signaling axis 9, 11, 12.   
Both the molecular mechanisms and the structural domains critical for Sprouty function are 
far from being understood. The CRD has been shown to be important for homo- and hetero-
oligomerization of Spry family members, as well as for translocation to the plasma 
membrane upon growth factor stimulation. A short stretch of aminoacids within the CRD 
that bind to Raf-1 have also been shown to be important for Sprouty function. Srpy1 and 
Spry2 also bind to caveolin-1 through a conserved Arginine located on their carboxy 
termini 7, 13, 14. Finally, the role of the conserved tyrosine in the N-terminus of Spry family 
members (Tyr53 in Spry1) is controversial. Thus, mutation of this tyrosine prevents the 
ability of Spry proteins to inhibit signaling by receptor tyrosine kinases in some models 15, 
16, 17 but fails to do so in others 18. While these discrepancies may reflect context-specific 
mechanisms of action of Sprouty proteins, they could also be a consequence of the 
experimental setting used in these experiments, consisting mainly on ectopic 
overexpression in cell lines.  
To begin to address this question we have generated knockin mice bearing a tyrosine to 
alanine mutation in residue 53 of Spry1. Analysis of Spry1knockin mice indicate that this 
tyrosine is absolutely required for Spry1 function during genitourinary (GU) development, 
as knockin mice faithfully phenocopy CAKUT observed in Spry1 knockout mice. Mice 
lacking this tyrosine present numerous ectopic UBs along the WD that will ultimately 
generate supernumerary kidneys. Ureter maturation is also defective in these animals, as 
ureters fail to detach from the WD and migrate to their final position, leading to 
vesicoureteral reflux. Finally, a series of internal genitalia malformations likely secondary 
to ureter maturation defects are also present in Spry1 knockin mice.   
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METHODS 
Mice 
All animal use was approved by the Animal Care Committee of the University of Lleida in 
accordance with the national and regional guidelines. Mice were maintained on a 12h 
light/dark cycle, and food and water was provided ad libitum. Mice knockout for Spry1 
(Spry1tm1.1Jdli) were described in 9. Ret EGFP mice (Rettm13.1Jmi, 19) were a gift from Dr. 
Sanjay Jain (Washington University, St Louis, USA). Both knockin and knockout mice 
used in this paper were on a mixed 50% C57BL/6 x 50% 129Sv genetic background. 
 
Generation of  Spry1Y53ANeo knockin mice 
The targeting vector consisted of an EcoRI fragment of genomic DNA of approximately 
11.5 Kb including the three exons of Spry1, cloned into pBluescript 9. A change of two 
nucleotides (TAC to GGC) in the third exon was introduced, converting tyrosine 53 into 
alanine. A neomycin-resistant cassette flanked by FRT sites was inserted into the BclI site 
for positive selection. For negative selection, a thymidine kinase (TK) cassette driven by 
the phosphoglycerate kinase (PGK) promoter was cloned into the SalI site of pBluescript. 
This vector was linearized with AdhI, and E14 ES cells were electroporated and selected in 
the presence of 0.250 mg/ml G418 plus 2µM Ganciclovir for 8 days. A total of 508 
resistant clones were isolated and grown in 96-well plates. The presence of correctly 
recombined clones was screened by PCR using primers 396F (5’- 
GTATAGGAACTTCTGATCATGATGGC-3’) and 409R (5’‐
CACCTAACAAAACCACAAGCTTAAGACC-3’), and a mixture of 30U Taq:1U Pfx 
(ThermoFisher). Correctly recombined clones yielded a ~4.5 kb band that was resolved in 
0.7% agarose gels. Genomic DNA from Spry1 knockout mice was used as a positive 
control as it was constructed following the same strategy. PCR-positive clones were 
confirmed by means of Southern Blot. Briefly, genomic DNA was digested overnight with 
either XbaI (5’ arm) or BglII (3’ arm). Membranes were hybridized with digoxigenin-
labeled probes generated by PCR using the PCR DIG labeling mix (Roche, cat # 1 835 289 
910) as per manufacturer’s instructions; and primers 390F (5’-
ACACAATGGAGGCATTTAAGCAGAA-3’) and 391R (5’-
ACGGTTATGTGTGGAATTACATGCA-3’) for the 5’ arm probe and 392F (5’-
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CTAACCATTGAGCTACCTCTCCAGCC-3’)  and 393R (5’-
GCTGTGACATAACCCCATGACCAAGG-3’) for the 3’ arm probe. Blots were 
developed on X-ray films using CDP* as a substrate (Roche). Two ES clones,  4AD4 and 
6DA1, were independently injected to obtain two lines of mice bearing the mutation. The 
phenotype of these mice was indistinguishable from each other. Most of the results were 
obtained with the 4AD4 clone. Spry1Y53ANeo mice were genotyped by PCR using 
primers 429F (5’-TATCAGCCAAGGGTTTCACTACGAG-3’), 430R (5’-
TCTAAGAGCACCTCAGAAAGCCAGA-3’), and 431R (5’-
CTACCGGTGGATGTGGAATGTGT-3’). After removal of the Neo cassette, Spry1Y53A 
mice were genotyped using primers 429F and 430R. 
 
Western blot and Immunoprecipitation 
Protein extracts from mouse tissues were obtained by mechanical lysis at 4ºC with NP40 
buffer (1% Nonidet P-40, 150mM NaCl, 50mM HEPES, 1mM EDTA and 1mM EGTA) 
supplemented with protease inhibitor cocktail (Roche) and phosphatase inhibitors (1mM 
NaVO4, 10mM NaF and 50mM β-Glycerophosphate). Western blot was performed as 
described 20. For immunoprecipitation, cells were lysed with NP40 buffer supplemented 
with protease and phosphatase inhibitors as above. Protein was immunoprecipitated 
overnight at 4ºC with the indicated antibodies plus Protein A/G magnetic beads (Pierce). 
Antibodies used were as follows: Anti-Spry1 (Cell Signalling, Cat# 13013 for Western blot 
and Cat# 12993 for immunoprecipitation), Anti β-actin (Santa Cruz, sc-1616), Anti-
phosphotyrosine (Millipore, Cat# 05-321), Anti-p53 (Santa Cruz, Cat# sc-126), Anti-
p21Cip1 (Millipore, Cat# 05-345), Anti-p19Arf (Abcam, Cat#  ab80), Anti-Spry2 (Sigma, 
Cat# S1444). 
 
Subcellular Fractionation and Palmitoylation Assay 
Subcellular fractionation was performed using the Subcellular Protein Fractionation Kit for 
Cultured Cells from Pierce following the manufacturer’s instructions. Antibodies used to 
confirm purity of the fractions included Anti-Caveolin-1 (BD, Cat# 610406), Anti-GAPDH 
(Abcam, Cat# 8245), Anti-SP-1 (Santa Cruz, Cat# sc-17824) and Anti-Vimentin (BD, Cat# 
550513). Palmitoylation assays were performed using the Acyl-RAC pulldown technique 
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exactly as described 21. Briefly, after blocking free thiols with methyl methanethiosulfonate 
(Sigma), lysates are split in half and palmitoyl thioester linkages are cleaved using NH2OH, 
or left intact. Newly liberated thiols are captured with thiopropyl Sepharose (Sigma) 
pulldown, and resolved by SDS-PAGE.  
 
Immunofluorescence and Immunohistochemistry 
Frozen sections were blocked with blocking buffer (4% BSA, 1% Triton X-100, 100 mM 
Glycine in PBS) for 1h at room temperature and incubated with either FITC-DBA (Vector) 
or Biotin-LTA (Vector) diluted in blocking buffer for an additional hour at RT. Slides 
containing Biotin-LTA were then incubated with Dylight 594-labeled streptavidin (Jackson 
Immunoresearch) for 1h at RT. For uroplakin staining, sections were blocked as above and 
incubated overnight at 4ºC with a rabbit polyclonal antibody (AUM 745) generously 
provided by Dr. Tung-Tien Sun (New York University). Next day, sections were incubated 
with Dylight 549-labeled secondary antibodies (Jackson). For WT1 (DAKO) 
immunohistochemistry, paraffin sections were dewaxed and rehydrated using a 
xylene/ethanol gradient followed by antigen retrieval (95 °C for 20 min in Tris/EDTA 
buffer, pH 9) using a PTLink apparatus (DAKO). Staining was performed by an 
Autostainer device (DAKO). Sections were counterstained with hematoxylin#. 
 
Quantitative RT-PCR 
Total RNA was extracted using TRIZOL reagent (ThermoFisher). RNA was reverse 
transcribed using the High-Capacity cDNA Reverse Transcription Kit (ThermoFisher) as 
per manufacturer’s instructions. Quantitative RT-PCR (qRT-PCR) reactions were 
performed by means of the SYBR green method, using a 2x Master mix qPCR Low Rox kit 
(PCR Biosystems). The 2-ΔΔCt method was used, normalizing to actin expression. Reverse 
transcriptase-minus and blank reactions were included in all experiments. Primers used 
were as follows: Actin, 616F: 5’-TTCTTTGCAGCTCCTTCGTT-3’ and 617R: 5’- 
ATGGAGGGGAATACAGCCC-3’, Spry1, 471F: 5’-CTCTGCGGGCTAAGGAGC-3’ 
and 472R: 5’-ACGCCGGCTGATCTTGC-3’; and Spry2, 620F: 5’-
AGAGGATTCAAGGGAGAGGG-3’ and 621R: 5’-AGAGGATTCAAGGGAGAGGG-3’. 
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Whole mount immunofluorescence 
For EGFP fluorescence, the GU system of embryos of the indicated ages was dissected and 
directly photographed under a Nikon SMZ18 fluorescence stereoscope coupled to a Nikon 
DS-Ri2 camera. For whole mount cytokeratin staining, embryos were fixed overnight at 
4ºC in 4% paraformaldehyde. Their GU systems were dissected next day and blocked in 
blocking buffer (4% BSA, 1% Triton X100,100mM glycine, 0.2% sodium azide in PBS) 
overnight at 4ºC with gentle agitation. GU systems were then incubated with a 1:100 
dilution of anti-cytokeratin antibody (DSHB, TROMA-I) in blocking buffer for 3-5 days at 
4ºC. After that, GU systems were washed three times in PBS 1% Triton X100 for 2 hours 
each at room temperature, and incubated with fluorescently labeled secondary antibodies 
(Jackson Immunoresearch) in blocking buffer overnight at 4ºC. Tissues were cleared in 1:2 
benzyl alcohol:benzyl benzoate (BABB) after being dehydrated through a graded series of 
methanol. Specimens were placed on coverslips and imaged using a Olympus Fluoview 
FV1000 confocal laser scanning microscope.  
 
Generation and validation of phospho-Y53 Spry1 specific antibody 
The anti-phospho-Y53 Spry1 antibody was produced by Abyntek (Derio, Spain). Rabbits 
were immunized with the peptide GSNEpYTEGPSVARRPAPRC conjugated to KLH, and 
antiserum was affinity-purified using the same phosphopeptide. We further purified 
phospho-antibodies by adsorbing them against the corresponding non-phosphopeptide 
attached to Aminolink resin (ThermoFisher). 293T cells were transfected with plasmids 
coding for wild type or Y53A HA-tagged mouse Spry1 by the calcium phosphate method. 
Before lysis, cells were stimulated or not with 50 ng/ml FGF (Preprotech) for ten minutes. 
Lysates were subjected to western blot using the pY53 Spry1 purified antibody diluted 
1/1000, or antibodies to HA (Sigma, Cat# 00000001186742300), phospho-ERK 
(Biolegend, Cat# 675502) or Actin (Santa Cruz, Cat# sc-1616).  
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RESULTS 
 
Generation of  Spry1Y53ANeo knockin mice 
To explore the role of Spry1 tyrosine 53 in vivo, we generated knockin mice bearing a 
tyrosine to alanine mutation in this residue. We followed the same strategy used to generate 
Spry1 knockout mice 9, but the targeting vector lacked loxP sites flanking the Spry1 single 
coding exon and contained a single nucleotide change generating a Y53A amino acid 
substitution instead (Figure 1A). ES cells were electroporated with the linearized construct 
and G418-resistant clones screened for homologous recombination by PCR as described in 
methods (Figure 1B, top panel). Targeted insertion of both homology arms in PCR-positive 
clones was confirmed by means of Southern Blot (Figure 1B, middle panel). The presence 
of the point mutation was confirmed by sequencing. Two independent ES clones, 4AD4 
and 6DA1, were used to generate heterozygous knockin mice bearing the Y53A mutation 
plus the Neo cassette (Spry1Y53ANeo/+). We next crossed Spry1Y53ANeo/+ animals to obtain 
knockin mice and examined their offspring. Spry1Y53ANeo/Y53ANeo were born at the 
expected Mendelian proportions (data not shown). At weaning, knockin mice were slightly 
smaller than wild type littermates (Figures 1C and 1D), and the number of homozygous 
mutant females recovered was less than expected, although this trend was not statistically 
significant (P=0.249 by Chi-Square test) (Figure 1E).  
 
Tyrosine 53 is the major phosphotyrosine of Spry1 
Immunoblot analysis revealed that Spry1 was present at slightly increased levels in brains 
from newborn Spry1Y53ANeo/Y53ANeo when compared to those from wild type littermates 
(Figure 2A, left panel). Importantly, tissues from knockout mice confirmed the specificity 
of the Spry1 antibody used. These differences in protein levels were not caused by 
increased mRNA levels (Figure 2A, right panel). We next analyzed expression of Sprouty1 
in E13.5 and newborn kidneys. At both ages, the amount of Sprouty1 was greatly increased 
in mutant mice (Figures 2B and 2C). Again, mRNA levels were unchanged (Figure 2C, 
middle panel), indicating that regulation of Sprouty1 levels by tyrosine 53 is post-
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transcriptional.  Interestingly, levels of Sprouty2 were modestly increased in kidneys from 
Spry1Y53ANeo/Y53ANeo mice. We next assessed the contribution of Spry1 tyrosine 53 to the 
global pattern of tyrosine phosphorylation of the protein. Dermal fibroblasts from newborn 
Spry1Y53ANeo/Y53ANeo mice and wild type littermates were placed in culture and stimulated 
with sodium pervanadate. After lysis, Spry1 was immunoprecipitated and probed with anti-
phosphotyrosine antibodies. Again, skin fibroblasts from Spry1 knockout mice served as 
negative control. As shown in Figure 3A, pervanadate caused a robust tyrosine 
phosphorylation of Spry1 that was severely reduced but not completely eliminated upon 
mutation of tyrosine 53. As expected, no band was found in immunoprecipitates from 
knockout cells. Thus, tyrosine 53 constitutes a major but not the only phosphorylatable 
tyrosine of Spry1. To confirm these observations, we generated a phospho-Y53 Spry1 
specific antibody. As expected, sodium pervanadate induced a robust phosphorylation of 
Spry1 immunoprecipitated from fibroblasts from wild type but not Spry1Y53ANeo/Y53ANeo 
mice (Figure 3B). Specificity of this new anti-phospho-Y53 Spry1 was confirmed using 
transfected 293T cells (Figure 3C). Finally, we wanted to confirm that mutation of tyrosine 
53 does not result in mislocalization of Sprouty1. In agreement with previous studies 22, 
both wild type and mutant Sprouty1 were localized to the membranous compartments of 
the cell (Figure 3D), and were palmitoylated (Figure 3E). 
 
Mutation of tyrosine 53 of Spry1 causes genitourinary defects identical to those found 
in Spry1 knockout mice  
Examination of Genitourinary (GU) systems of knockin animals at birth revealed a series of 
lower urinary tract abnormalities, among which bilateral megaureter was by far the most 
common. Duplex and blind ureters were also observed, albeit to a much lower incidence. 
Histologic examination of kidneys revealed that they consisted on two or more 
supernumerary kidneys fused together, with nephrogenic zones not restricted to the 
periphery (Figure 4B) that stained positive for the marker Wilms Tumor (WT1) (Figure 
5A), large cystic cavities, and hydroureteronephrosis (Figures 4A and 4B). These defects 
were fully penetrant in homozygous mice, with a small proportion (~10%) of heterozygous 
mice presenting unilateral megaureter with concomitant kidney defects (Figures 4D and 
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4E). Moreover, all these abnormalities were indistinguishable from those found in Spry1 
knockout mice, indicating that tyrosine 53 is essential for the functions of Spry1 in 
genitourinary development (Figures 4A and 4B). On the other hand, female 
Spry1Y53ANeo/Y53ANeo mice presented a series of gross internal genitalia abnormalities at birth 
including ovaries ectopically placed ventral to the kidneys, with uterine horns attached to 
ureters and in most cases ending blindly instead of fusing to each other (Figure 4C). 
Knockin males presented testis set next to kidneys, vasa deferentia were fused to ureters 
and consequently seminal vesicles were absent (Figure 4C). Again, all these malformations 
were also found in Spry1 knockout mice  [Figure 4A and 9]. Knockin mice generated from 
the two independent ES clones presented similar phenotypes. Most of the analyses were 
performed with the clone 4AD4. Close examination of newborn kidneys from both knockin 
and knockout mice indicated that the cystic cavities stained positive for the collecting duct 
marker Dolichos Biflorus Agglutinin (DBA) but not the proximal tubule marker Lotus 
Tetragonolobus agglutinin (LTA) as previously described 9 (Figure 5B). As expected, 
hydroureters and swollen renal pelvises stained positive for the urothelium marker 
uroplakin (Up, Figure 5B). 
 
Aberrant UB development generates supernumerary kidneys in Spry1 knockin mice 
It has been previously shown that these urogenital defects are readily rescued by genetically 
reducing the activation of the GDNF/Ret pathway. Thus, kidney defects found in Spry1 are 
caused by the emergence of supernumerary, ectopic ureteric buds giving rise to multiplex 
kidneys owing to hypersensitivity of the WD to GDNF signaling.  To further investigate the 
developmental origin of GU abnormalities of Spry1Y53A knockin mice we crossed 
Spry1Y53ANeo/+ to mice expressing EGFP from the Ret locus19, thus allowing easy tracking 
of the WD and the UB (Figure 6A). The UB formed normally in both knockin and 
knockout mice at E10.5, however several protuberances of the WD cranial to the ureteric 
bud were observed in mutant but not wild type animals (Figure 6B). At E11.5, a T-shaped 
ureteric bud had emerged from the WD in wild type mice. At this age the UB of either 
knockin or knockout mice had also two well-formed branches but the stalk was much 
shorter than in wild type embryos, and numerous ectopic UBs grew cranially. By E12.5 a 
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well-developed ureter, completely separated from the WD, and a short common nephric 
duct (cnd) were present in wild type mice. In contrast, metanephric kidneys from both 
Spy1Y53ANeo/Y53ANeo and Spry1-/- embryos remained in close proximity to the WD, had many 
shorter, supernumerary ureteric buds and a much longer cnd (Figure 6B).  
 
Defective ureter maturation causes vesicoureteral reflux, megaureter and internal 
genitalia defects in Spry1 knockin mice 
To image genitourinary development at older embryonic ages we performed whole mount 
cytokeratin staining as Ret expression gets progressively confined to UB tips and caudal 
WD, including seminal vesicles, but not ureters (19 and data not shown). In wild type E12.5 
embryos, as observed with EGFP fluorescence, long, completely separated ureters 
converged with the WD behind a very short cnd. One day later ureters had elongated 
caudally and cnds were almost eliminated (Figure 7A, left panels). In contrast, at E12.5 
knockin mice presented an flat, triangle-shaped structure [Figure 7A, top right panel 
(arrow)], that was continuous with in a very long cnd on its caudal side. At E13.5 kidneys 
from knockin mice were caudally misplaced, in close proximity to this enlarged planar 
structure (Figure 7A, bottom right panel), to where both multiple UBs and the WD were 
connected (Figure 7B). At E15.5, numerous ectopic kidneys arising at different points of 
the Wolffian duct and that attached together to form a single anatomic unit were present in 
knockin mice (Figure 7D). Each of these supernumerary kidneys had an ureter that, 
together with the WD, fused to the flat triangle-shaped structure, which was continuous 
with a greatly enlarged cnd, acquiring the shape of a megaureter (Figure 7C, arrows). At 
this age, ureter maturation had proceeded completely in wild type animals, with ureters 
completely segregated from the WD. Ureters connected to the bladder at their definitive 
location (Figure 7E, arrowheads), whereas WDs remained attached to the pelvic urethra 
(Figure 7E, asterisks). Ureter maturation never happened in mutant mice, thus leaving WD 
and ureters fused together and connecting to the pelvic urethra (Figure 7E). Such broad, 
ectopic insertion precluded correct formation of the vesicoureteral junction, giving rise to 
vesicoureteral reflux as demonstrated by trypan blue injection into the bladder (Figure 7D, 
bottom panel). This observation explains both the presence of urine-filled megaureters and 
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hydroureteronephrosis found in newborn mutant mice. On the other hand, Müllerian ducts 
failed to fuse to each other at the midline but instead coiled around giving rise to blind 
uterine horns found in newborn mice (Figure 7D, top panel). Finally, failure or ureters to 
segregate from WD cause fusion of vasa deferentia to ureters in newborn mutant males. 
In conclusion, we have demonstrated that mutation of the N-terminal tyrosine of Sprouty1 
leads to formation of ectopic ureteric buds that ultimately will form supernumerary 
kidneys, thus phenocopying Spry1 knockout mice. A more detailed analysis of ureter 
maturation reveals a series of defects that eventually lead to formation of megaureters and 
vesicoureteral reflux.   
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DISCUSSION 
Phosphorylation of the conserved N-terminal tyrosine is the most abundant post-
translational modification (PTM) detected in Sprouty family members, representing 63-
77% of total PMTs found in high-throughput proteomic experiments [PhosphositePlus 23]. 
Accordingly, we have found that tyrosine 53 is the major (but not the only) 
phosphotyrosine in mouse Sprouty1. Besides tyrosine 53, the same high-throughput 
experiments have identified two extra phosphotyrosines in Sprouty1, namely tyrosine 89 
(identified 50 times vs. 247 times for tyrosine 53) and tyrosine 304 (7 times). The function 
of these tyrosines is essentially unexplored and deserves future investigation. Other C-
terminal tyrosines found in Sprouty2 such as tyrosines 227, 269 and 283 24 have not being 
identified on its phosphorylated form in Sprouty1. 
We have found that knockin mice lacking tyrosine 53 phenocopy the renal malformations 
found in Spry1-/- mice, namely emergence of ectopic UBs leading to supernumerary 
kidneys. The role of the conserved N-terminal tyrosine of Sprouty proteins has been 
previously tested by several independent laboratories, essentially in the context of 
Extracellular-signal regulated kinase (ERK) pathway inhibition —regarded as the primary 
target of Sprouty proteins. While some studies showed that mutation of that tyrosine 
renders Sprouty proteins unable to block the ERK pathway 17, 16, 15, others have found that 
its phosphorylation is dispensable for inhibition of the pathway 18. These discrepancies 
might be related to differences in the context in which these experiments were conducted, 
including the cell type, the growth factors used, or the family member(s) analyzed, but also 
can reflect two distinct modes of action of these proteins. Thus, in experimental paradigms 
where Sprouty proteins act at the level of Raf-1 25, 18, phosphorylation of this tyrosine 
would be dispensable for their function, whereas in models where Sprouty proteins act 
upstream of Ras 16, 15, this tyrosine would be absolutely necessary for their activity. Our 
data clearly show that tyrosine 53 of Spry1 is essential for its function at least in the context 
of genitourinary development, favoring the second model. However, we cannot rule out the 
possibility that in other cellular systems mutation of tyrosine 53 would have no effect on 
the activity of Spry1.  
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We also describe ureter maturation defects in our mutant mice, essentially consisting on 
failure of the ureters to elongate, to properly separate from the WD and therefore to migrate 
to their definitive insertion at the bladder. It has been previously described that excessive 
activation of the ERK pathway in the developing lung leads to aberrant mitotic spindle 
orientation and abnormal airway shape 26. We hypothesize that the same mechanism would 
explain the some of the above defects. Thus, in mutant mice epithelial cells from the UBs 
would not undergo mitotic divisions oriented parallel to the longitudinal axis of the ureter, 
but rather place their mitotic spindles in a disorganized fashion, leading to the appearance 
of  the flat, triangle-shaped structure connecting UBs and WD. In parallel, the cnd fails to 
degenerate and ends up forming the caudal part of the ectopically inserted megaureters 
found in Spry1 mutant mice. It has been previously shown that degeneration of the cnd by 
apoptosis is crucial for proper ureter detachment from the WD during ureter maturation 3, 4. 
On the other hand, increased ERK activity in Ret Y1015F mutants leads to decreased 
apoptosis of the cnd 19. Finally, these ureter maturation defects are rescued by genetically 
reducing the activation of the GDNF-Ret signaling pathway 9, 11, 12. Altogether, these 
observations strongly suggest that mutation of Sprouty1 leads to an increase of Ret-derived 
ERK phosphorylation, that in turns inhibits apoptosis of the cnd.     
Mechanistically, how deletion of the N-terminal tyrosine blocks Sprouty function is still a 
matter of debate. It was initially described that this phosphotyrosine provides a binding site 
for the SH2 domain of Grb2, and therefore sequestering of this adaptor by Sprouty proteins 
upon growth factor stimulation would uncouple RTK phosphorylation from ERK pathway 
activation 16. However, later on it was shown that association of Grb2 to Sprouty was 
independent of tyrosine phosphorylation 15. Perhaps the most widely accepted protein 
binding this phosphotyrosine is the ubiquitin ligase c-Cbl. According to one model Spry2 
sequesters c-Cbl away from the EGFR, thus blocking its proteasomal degradation and 
potentiating signaling by EGF 27, 28, 29, 30. However, such mechanism obviously only 
operates in systems where Spry2 activates instead of inhibits EGFR signaling, but won’t 
explain how this tyrosine inhibits signaling by FGFR or Ret. In a more general scenario, the 
functional consequence of binding of c-Cbl to Spry2 is proteasomal degradation of the 
latter 31, 27, 15. Our data are in agreement with these observations, as steady-state levels of 
Spry1 are increased in brain lysates from Spry1Y53A/Y53A mice when compared to their wild 
17 
 
type littermates. However, attenuation of FGF-mediated ERK phosphorylation by Spry2 is 
not dependent on c-Cbl, as Spry2 efficiently inhibits ERK phosphorylation in MEFs from 
c-Cbl-/- mice 15. In conclusion, the mechanisms by which the N-terminal tyrosine of Sprouty 
proteins mediate their function require further investigation. We believe that our 
Spry1Y53A knockin mouse represents an excellent model system to pursue this objective.   
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FIGURE LEGENDS 
Figure 1. Generation of Spry1 Y53A knockin mice. (A) Targeting strategy used, 
including primers used for PCR screening and genotyping, and southern blot probes (black 
horizontal bars). (B) A first screening was performed using by PCR using primers 396F and 
409R (top panel). Tail DNA from Spry1-/- mice served as positive control. PCR-positive 
clones (asterisk) were confirmed by southern blot (middle panel), and SpryY53ANeo/+ mice 
were genotyped using primers 429F, 430R and 431R (lower panel). (C, D) Reduced weight 
of male and female knockin mice at weaning. P-values were calculated by the Mann-
Whitney test. (E) Allelic frequencies at weaning (3-4 weeks).  
 
Figure 2. Expression of wild type and mutant Sprouty1. (A) Levels of Spry1 from 
newborn brains of the indicated genotypes were measured by western blot (left panel). 
Right panel, quantification of protein and mRNA levels from newborn brains of the 
indicated genotypes. Equal mRNA levels indicate that regulation of protein levels by 
tyrosine 53 is post-transcriptional. Asterisk denotes P=0.11 by Mann-Whitney test. (B) 
Protein levels of E13.5 kidneys from the indicated genotypes. Note much higher levels in 
knockin metanephroi. (C) Sprouty1 protein and mRNA levels of newborn kidneys from the 
indicated genotypes. Short and long exposures of Sprouty1 immunoblots are shown to 
illustrate the difference between genotypes. Levels of Sprouty2 are included for 
comparison. The number in parentheses indicate sample number in all graphs. 
 
Figure 3. Characterization of Spry1 Y53A protein. (A, B) Spry1 was 
immunoprecipitated from pervanadate-stimulated skin fibroblasts of the depicted 
genotypes, and membranes probed with the indicated antibodies. NS, non-specific band. 
IgG-L and IgG-H, low molecular and high molecular weight immunoglobulin chains. (C) 
Validation of phospho-Y53 Spry1 antibody. 293T cells were transfected with empty vector 
or plasmids coding for HA-tagged wild type or Y53A mouse Spry1. Cells were stimulated 
or not with FGF for 10 min, lysed and resolved by SDS-PAGE. Membranes were incubated 
with the indicated antibodies. Note that overexpression of Sprouty1 in 293T cells leads to 
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constitutive phosphorylation of tyrosine 53. (D) Subcellular fractionation of skin fibroblast 
extracts indicates that both wild type and Y53A Sprouty1 proteins localize to the 
membranous fraction of the cell. GAPDH, Caveolin-1, SP-1 and vimentin are markers of 
Cytosolic (Cyto), Membranous (Memb), Nuclear (Nuc) and Cytoskeletal (Cskel) fractions, 
respectively. (E) Both wild type and Y53A Sprouty1 are palmitoylated. The presence of a 
band in the NH2OH-treated lysates from skin fibroblasts indicates palmitoylation of the 
protein (see methods for details).  
 
Figure 4 . Spry1Y53ANeo/Y53ANeo phenocopy Spry1-/- mice in terms of genitourinary 
development. (A) Gross anatomy of newborn GU from the indicated genotypes (top 
panel). Hematoxylin-eosin stained sections of newborn kidneys of the indicated genotypes 
(middle panel). (B) Higher magnification of sections from the indicated genotypes showing 
ectopic nephrogenic zones and cystic cavities. Scale bar, 100 µm. (C) Detail of some GU 
abnormalities found in Spry1Y53ANeo/Y53ANeo mice including duplex ureters (left), blind 
uterine horns (middle) and vasa deferentia fused to ureters (right). (D) Unilateral CAKUT 
present in ~10% of Spry1Y53ANeo/+ mice. (E) Quantification of GU defects found in newborn 
mice of the indicated genotypes. Ad, adrenal gland; K, kidney; Ov, ovary; T, testis; Ur, 
ureter; Ut, uterus; Vd, vas deferens.  
 
Figure 5. Characterization of kidneys from newborn Spry1 knockin and knockout 
mice. (A) Wilms Tumor (WT1) staining of the ectopic nephrogenic zones. Note WT1- 
positive developing and mature nephrons, but not cystic cavities (B) Dolichos Biflorus 
Agglutinin (DBA) and Lotus Tetragonolobus agglutinin (LTA) and uroplakin (Up) staining 
of newborn kidneys from the indicated genotypes. Cysts are DBA-positive, revealing their 
collecting duct origin. Scale bars: 200 µm for 4x and 20 µm for 40x pictures. 
 
Figure 6. Aberrant ureteric bud development in Spry1 Y53A mice is indistinguishable 
to that of and Spry1 knockout mice. (A) Diagram showing Ret and Spry1 loci and mouse 
crosses to generate genotypes of interest. (B) EGFP fluorescence of UB and WD 
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development from embryos of the indicated ages and genotypes (all of them bearing one 
RetEGFP allele to allow visualization of these structures). Note ectopic UBs (arrowheads) 
and long common nephric ducts (cnd, brackets) in both Spry1 knockin and knockout 
mutant mice. WD, Wolffian duct. 
 
Figure 7. Ureter maturation defects leading to vesicoureteral reflux in Spry1 knockin 
mice. (A) Whole mount cytokeratin staining of embryonic GU system of the indicated ages 
and genotypes. Note long cnd and the presence of a flat, triangle-shaped structure 
connecting WD, UBs and cnd in mutant mice (arrow). Also note failure of kidneys to 
migrate away from the point at which WD and UBs converge. G, gut. (B) Detail of E13.5 
mutant GU stained with cytokeratin. Confocal stacks were divided in ventral (Z1) and 
dorsal (Z2) sections and pseudocolored in green and red for clarity. Note how the WD 
(arrowheads) is continuous with the triangle-shaped structure (arrow) and the ureter 
(asterisk). Note also how ectopic UBs integrate into one kidney. (C) Cytokeratin staining of 
GU systems from E15.5 embryos. The triangle-shaped structure (arrow) is continuous with 
an enlarged cnd, and together from a megaureter. MD, Müllerian duct. (D) Stereoscope 
image of knockin female GU shown in C allows clear visualization of supernumerary 
kidneys (K1 to K5) and ureters (Ur1 to Ur5) (E) Top panel: Detail of C showing complete 
separation between ureters (Ur), which insert into the bladder (Bl, arrowheads) and WDs, 
which join the pelvic urethra (PUr) at the points marked with asterisks, in wild type 
embryos. In knockin embryos, the cnd insert directly into the PUr. Note the Müllerian ducts 
(MD, arrows) coiling around instead of fusing to each other at the midline. Bottom panel, 
injection of trypan blue into the bladder of wild type and mutant dissected GU from 
newborn mice show vesicoureteral reflux in the latter.  
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